250 related articles for article (PubMed ID: 26661562)
1. mTOR pathway protein immunoexpression as a prognostic factor for survival in head and neck cancer patients: a systematic review and meta-analysis.
Marques AE; Elias ST; Porporatti AL; Castilho RM; Squarize CH; De Luca Canto G; Guerra EN
J Oral Pathol Med; 2016 May; 45(5):319-28. PubMed ID: 26661562
[TBL] [Abstract][Full Text] [Related]
2. p-mTOR, p-ERK and PTEN Expression in Tumor Biopsies and Organoids as Predictive Biomarkers for Patients with HPV Negative Head and Neck Cancer.
de Kort WWB; de Ruiter EJ; Haakma WE; Driehuis E; Devriese LA; van Es RJJ; Willems SM
Head Neck Pathol; 2023 Sep; 17(3):697-707. PubMed ID: 37486536
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.
Li S; Wang Z; Huang J; Cheng S; Du H; Che G; Peng Y
BMC Cancer; 2016 Nov; 16(1):877. PubMed ID: 27835987
[TBL] [Abstract][Full Text] [Related]
4. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
[TBL] [Abstract][Full Text] [Related]
5. Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas.
García-Carracedo D; Villaronga MÁ; Álvarez-Teijeiro S; Hermida-Prado F; Santamaría I; Allonca E; Suárez-Fernández L; Gonzalez MV; Balbín M; Astudillo A; Martínez-Camblor P; Su GH; Rodrigo JP; García-Pedrero JM
Oncotarget; 2016 May; 7(20):29780-93. PubMed ID: 27119232
[TBL] [Abstract][Full Text] [Related]
6. The prognostic and predictive value of excision repair cross-complementation group 1 (ERCC1) protein in 1288 patients with head and neck squamous cell carcinoma treated with platinum-based therapy: a meta-analysis.
Bišof V; Zajc Petranović M; Rakušić Z; Samardžić KR; Juretić A
Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2305-17. PubMed ID: 26179868
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Cancer Stem Cell Markers in Head and Neck Squamous Cell Carcinoma: a Meta-analysis.
Fan Z; Li M; Chen X; Wang J; Liang X; Wang H; Wang Z; Cheng B; Xia J
Sci Rep; 2017 Feb; 7():43008. PubMed ID: 28220856
[TBL] [Abstract][Full Text] [Related]
8. Is E-cadherin immunoexpression a prognostic factor for head and neck squamous cell carcinoma (HNSCC)? A systematic review and meta-analysis.
Zhao Z; Ge J; Sun Y; Tian L; Lu J; Liu M; Zhao Y
Oral Oncol; 2012 Sep; 48(9):761-7. PubMed ID: 22455948
[TBL] [Abstract][Full Text] [Related]
9. The EGFR-mTOR pathway and laryngeal cancer angiogenesis.
Lionello M; Lovato A; Staffieri A; Blandamura S; Turato C; Giacomelli L; Staffieri C; Marioni G
Eur Arch Otorhinolaryngol; 2014 Apr; 271(4):757-64. PubMed ID: 24065188
[TBL] [Abstract][Full Text] [Related]
10. P-mTOR Expression and Implication in Breast Carcinoma: A Systematic Review and Meta-Analysis.
Ding XF; Li LF; Zhou XL; Guo LN; Dou MM; Chi YY; Wu SX; Zhang YN; Shan ZZ; Zhang YJ; Wang F; Fan QX; Zhao J; Sun TW
PLoS One; 2017; 12(1):e0170302. PubMed ID: 28114374
[TBL] [Abstract][Full Text] [Related]
11. Study of the diagnosis and treatment of cancer located in the head and neck and correlation with expression of prognostic markers.
Bădulescu F; Bădulescu A; Crişan A; Popescu FC
Rom J Morphol Embryol; 2013; 54(3):487-97. PubMed ID: 24068395
[TBL] [Abstract][Full Text] [Related]
12. The lymphocyte-to-monocyte ratio as a prognostic indicator in head and neck cancer: a systematic review and meta-analysis.
Tham T; Olson C; Khaymovich J; Herman SW; Costantino PD
Eur Arch Otorhinolaryngol; 2018 Jul; 275(7):1663-1670. PubMed ID: 29651542
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment neutrophil to lymphocyte ratio in determining the prognosis of head and neck cancer: a meta-analysis.
Yu Y; Wang H; Yan A; Wang H; Li X; Liu J; Li W
BMC Cancer; 2018 Apr; 18(1):383. PubMed ID: 29618336
[TBL] [Abstract][Full Text] [Related]
14. Impact of p16 expression, nodal status, and smoking on oncologic outcomes of patients with head and neck unknown primary squamous cell carcinoma.
Dixon PR; Au M; Hosni A; Perez-Ordonez B; Weinreb I; Xu W; Song Y; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
Head Neck; 2016 Sep; 38(9):1347-53. PubMed ID: 27002481
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of miRNAs in Head and Neck Cancers: A Comprehensive Systematic and Meta-Analysis.
Kumarasamy C; Madhav MR; Sabarimurugan S; Krishnan S; Baxi S; Gupta A; Gothandam KM; Jayaraj R
Cells; 2019 Jul; 8(8):. PubMed ID: 31349668
[TBL] [Abstract][Full Text] [Related]
16. Role of EGFR as a prognostic factor for survival in head and neck cancer: a meta-analysis.
Keren S; Shoude Z; Lu Z; Beibei Y
Tumour Biol; 2014 Mar; 35(3):2285-95. PubMed ID: 24234257
[TBL] [Abstract][Full Text] [Related]
17. p-S6 as a Prognostic Biomarker in Canine Oral Squamous Cell Carcinoma.
Delgado L; Brilhante-Simões P; Garcez F; Monteiro L; Pires I; Prada J
Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883491
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of mTOR and PTEN in Patients with Esophageal Squamous Cell Carcinoma.
Lu J; Pan Y; Xia X; Gu Y; Lei Y
Biomed Res Int; 2015; 2015():417210. PubMed ID: 26357655
[TBL] [Abstract][Full Text] [Related]
19. Sex determining region Y-box 2 is a prognostic factor for head and neck squamous cell carcinoma: Evidence from 11 published investigations.
Li B; Chen M; Pan MX
J Cancer Res Ther; 2020; 16(3):434-439. PubMed ID: 32719247
[TBL] [Abstract][Full Text] [Related]
20. Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpression.
Alterio D; Marvaso G; Maffini F; Gandini S; Chiocca S; Ferrari A; Preda L; Rocca MC; Lepanto D; Fodor C; Volpe S; Dicuonzo S; Laudati A; Giugliano G; Ansarin M; Jereczek-Fossa BA
Med Oncol; 2017 Jun; 34(6):107. PubMed ID: 28452036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]